Diclofenac Sodium Gel
Product Images NDC 67296-2155

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 67296-2155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Diclofenac Fig1)

FDA Label Image

Figure (Diclofenac Fig10)

FDA Label Image

Figure (Diclofenac Fig11)

FDA Label Image

Figure (Diclofenac Fig12)

FDA Label Image

Figure (Diclofenac Fig13)

Figure (Diclofenac Fig13)
This text appears to discuss different states of cartilage health, including worn-away, healthy, and broken cartilage. It may be related to a medical or orthopedic context.*
FDA Label Image

Figure (Diclofenac Fig14)

FDA Label Image

Package Label-principal Display Panel (1% w/w tube Label (100 g Bottle))

Package Label-principal Display Panel (1% w/w tube Label (100 g Bottle))
Diclofenac Sodium Topical Gel is a 1% arthritis pain reliever designed for external use only. It is an NSAID (Nonsteroidal Anti-Inflammatory Drug) comparable to Voltaren® Arthritis Pain Relief gel. The gel is intended for relieving arthritis pain and should be used as directed. The product contains important warnings regarding potential allergic reactions, liver damage, stomach bleeding, heart attack, and stroke risks. Users are advised to seek medical help if an allergic reaction occurs and to avoid prolonged or excessive use. This product should not be used during the later stages of pregnancy without medical approval. Keep out of reach of children and store at 20° to 25°C (68° to 77°F). For more information, refer to the provided User Guide and dosing card. If you have any questions or comments, contact the distributor at 1-855-274-4122.*
FDA Label Image

Package Label-principal Display Panel (1% w/w Container Carton Label (100 g Bottle))

FDA Label Image

Package Label-principal Display Panel (1% w/w Tube Carton Label (350 g tube))

Package Label-principal Display Panel (1% w/w Tube Carton Label (350 g tube))
This text describes a medicated gel, Diclofenac Sodium Topical Gel, 1%, designed as an arthritis pain reliever and anti-inflammatory treatment for various areas in the body such as the wrist, elbow, foot, and ankle. It emphasizes the need to use the enclosed dosing card for accurate dosage measurement and specifies that it is not for use on other body areas like the back or shoulder. Additionally, it mentions that it is an original prescription strength product by AUROHEALTH and is for daily treatment of arthritis pain only.*
FDA Label Image

Figure (Diclofenac Fig2)

FDA Label Image

Figure (Diclofenac Fig3)

FDA Label Image

Figure (Diclofenac Fig4)

FDA Label Image

Figure (Diclofenac Fig5)

Figure (Diclofenac Fig5)
These are time periods in a day: Start of the day, Middle of the day, Late afternoon, End of the day.*
FDA Label Image

Figure (Diclofenac Fig6)

FDA Label Image

Figure (Diclofenac Fig7)

FDA Label Image

Figure (Diclofenac Fig8)

FDA Label Image

Figure (Diclofenac Fig9)

Figure (Diclofenac Fig9)
This appears to be a guide to evaluating and examining different parts of the body. It covers upper body areas such as the elbow, wrist, and hand, and lower body areas such as the sides, kneecap, back, ankle, and foot. The guide outlines specific areas to include in the examination for each body part, such as sides, inner, outer, top, bottom, palm, fingers, front, back, sole, top of foot, and toes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.